Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The presynaptic cholinergic terminal is the specialized region at the end of a cholinergic neuron’s axon responsible for the synthesis, storage, and regulated release of the neurotransmitter acetylcholine (ACh)[5][8][9]. Upon arrival of an action potential, voltage-dependent calcium channels trigger the fusion of synaptic vesicles with the plasma membrane, releasing ACh into the synaptic cleft, where it acts on postsynaptic and sometimes presynaptic acetylcholine receptors (both nicotinic and muscarinic types)[5][7]. Enzymatic breakdown of ACh by acetylcholinesterase in the synaptic cleft ensures the transient nature of cholinergic signaling[5][9]. Presynaptic cholinergic terminals play essential roles in neuromuscular junctions, autonomic ganglia, and widespread areas of the central nervous system, particularly in circuits critical for memory, attention, and arousal[7][9]. Loss or dysfunction of presynaptic cholinergic terminals is a hallmark of major neurodegenerative disorders, notably Alzheimer’s disease[7][9]. However, as an anatomical structure containing many molecular components (such as choline acetyltransferase, the vesicular ACh transporter, voltage-gated calcium channels, and others), it is not a molecular therapeutic target but instead the site where many therapeutic targets reside[5][8][9].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Presynaptic cholinergic terminal.